Notable Earnings Before Thursday's Open
Albemarle Is Out of Wells Fargo's Signature Picks
AbbVie Earnings Preview: Will Humira's Expiry, New CEO Fuel A Bullish Surge?
Dren Bio Announces Strategic Collaboration With Novartis To Develop Novel Targeted Myeloid Engagers For Cancer; Dren Bio To Receive Total Upfront Consideration Of $150M And Is Eligible To Receive Milestone Payments And Tiered Royalties
Biogen, Sage Discontinue Neuro Candidate After Mid-stage Setback
Pfizer/ Sangamo Gene Therapy for Hemophilia A Succeeds in Late-stage Trial